Search results
Results from the WOW.Com Content Network
CD25 deficiency or interleukin 2 receptor alpha deficiency is an immunodeficiency disorder associated with mutations in the interleukin 2 receptor alpha (CD25) (IL2RA) gene. The mutations cause expression of a defective α chain or complete absence thereof, an essential part of high-affinity interleukin-2 (IL-2) receptors.
The interleukin-2 receptor alpha chain (also called Tac antigen, P55, and mainly CD25) is a protein involved in the assembly of the high-affinity interleukin-2 receptor, consisting of alpha (IL2RA), beta and the common gamma chain ().
In 2016, Novartis initiated an anti-GITR (GWN323) trial. [24] CD358: Death receptor 6 or tumor necrosis factor receptor superfamily member 21 (TNFRSF21), it activates the JNK and NF-κB pathways and is mostly expressed in the thymus, spleen and white blood cells. CD360: IL21R (Interleukin 21 receptor). It is a cytokine receptor for interleukin ...
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
John Emil List (September 17, 1925 – March 21, 2008) was an American mass murderer [1] and long-time fugitive.On November 9, 1971, he killed his wife, mother, and three children at their home in Westfield, New Jersey, and then disappeared.
16185 Ensembl ENSG00000100385 ENSMUSG00000068227 UniProt P14784 P16297 RefSeq (mRNA) NM_000878 NM_001346222 NM_001346223 NM_008368 RefSeq (protein) NP_000869 NP_001333151 NP_001333152 NP_032394 Location (UCSC) Chr 22: 37.13 – 37.18 Mb Chr 15: 78.36 – 78.38 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Interleukin-2 receptor subunit beta is a protein that in humans is encoded by ...
Basiliximab is indicated for the prophylaxis of acute organ rejection in de-novo allogeneic renal transplantation. [3] It is to be used concomitantly with ciclosporin for microemulsion- and corticosteroid-based immunosuppression, in people with panel reactive antibodies less than 80%, or in a triple maintenance immunosuppressive regimen containing ciclosporin for microemulsion, corticosteroids ...
Daclizumab was used to treat adults with relapsing forms of multiple sclerosis. [6] It is administered subcutaneously. [7]In clinical trials, decreases of 45% in annualized relapse rate have been reported, as well as a 41% reduction in the proportion of patients who relapsed, and a 54% reduction in the number of new lesions. [7]